Literature DB >> 35693054

Screening of group B Streptococcus infection in pregnancy and neonatal outcomes in the province of Trento, Italy.

Silvano Piffer1, Roberto Rizzello1, Mariangela Pedron1, Laura Dellanna2, Anna Lina Lauriola3.   

Abstract

The study analyzes the trend of group B streptococcal (GBS) infection in pregnancy in the province of Trento, Italy, where a universal screening of GBS infection in pregnancy has been active for some time. Data from pregnant women who gave birth at local maternity units between 2015-2019 were obtained from birth attendance certificates (BAC), the main - and mandatory - source of information for monitoring pregnancies, births and neonatal health in Italy. The BAC used in the province of Trento acquires the results of a vast range of infections in pregnancy. The data collected from the BAC were integrated with those provided by the Hospital Information System (SIO). The occurrence of neonatal GBS infection was investigated on 2019 birth cohort, using the hospital discharge archive as an ancillary information source. Between 2015-2019, 20,905 pregnant women received care at maternity units of the province of Trento, Italy, of whom 25.5% were foreigners. The average coverage of GBS testing in pregnancy was 91.8% (95% CI 91.25-92.35) without significant variations from one year to the next. Test coverage varies in relation to maternity units and some socio-demographic characteristics of mothers. The average proportion of GBS positive cases over the study period was 21.0% (95% CI 20.7-21.3), a value that does not show statistically significant changes from one year to the next. The proportion of positive cases appears uneven among the subgroups of pregnant women considered, even if the differences are not statistically significant. In the 2019 birth cohort, newborns to GBS-positive mothers had an excess of stillbirths, of those born with Apgar at 5 minutes <7 and hospitalized at birth. However, these excesses were not statistically significant. Intravenous Antibiotic Prophylaxis (IAP) was performed in 86.8% of births from GBS positive mothers who had an indication for IAP. IAP was inadequate in 7.4% of the GBS positive mothers. Postnatal evaluation of 783 live births to GBS positive mothers identified 3 cases of early neonatal GBS infection. The incidence of neonatal GBS infection over the whole series of live births is 0.71/1,000 (95% CI 0.56-0.86), 0.68/1000 (CI 95% 0.55-0.79) in Italians and 1.07/1000 (95% CI 0.45-1.65) in foreigners. Data collection on infections in pregnancy through BAC allows area-based assessment. The quality of the data recorded in the BAC can be considered satisfactory but it was necessary to access to other information sources. The local availability of various information sources should allow periodic audits and closer monitoring of neonatal GBS infection.
Copyright © 2016 - 2022 InfezMed.

Entities:  

Keywords:  Group B streptococcus infection; birth attendance certificate; neonatal infection; pregnancy; universal screening

Year:  2022        PMID: 35693054      PMCID: PMC9177189          DOI: 10.53854/liim-3002-11

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  34 in total

1.  Group B streptococcal disease in UK and Irish infants younger than 90 days.

Authors:  Paul T Heath; Gail Balfour; Abbie M Weisner; Androulla Efstratiou; Theresa L Lamagni; Helen Tighe; Liam A F O'Connell; Mary Cafferkey; Neville Q Verlander; Angus Nicoll; A Christine McCartney
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

Review 2.  A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States.

Authors:  Peggy Dermer; Connie Lee; Julie Eggert; Brian Few
Journal:  J Pediatr Nurs       Date:  2004-10       Impact factor: 2.145

Review 3.  Prevalence of maternal group B streptococcal colonisation in European countries.

Authors:  Egle Barcaite; Arnoldas Bartusevicius; Rasa Tameliene; Mindaugas Kliucinskas; Laima Maleckiene; Ruta Nadisauskiene
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

4.  Characteristics of neonatal GBS disease during a multicentre study (2007-2010) and in the year 2012.

Authors:  Roberta Creti; Alberto Berardi; Lucilla Baldassarri; Monica Imperi; Marco Pataracchia; Giovanna Alfarone; Simona Recchia
Journal:  Ann Ist Super Sanita       Date:  2013       Impact factor: 1.663

5.  Group B streptococcus antimicrobial resistance in neonates born to group B streptococcus-colonized mothers: Single-center survey.

Authors:  Yi-Ping Li; Chi-Man Kuok; Shin-Yu Lin; Wu-Shiun Hsieh; Ming-Kwang Shyu
Journal:  J Obstet Gynaecol Res       Date:  2016-08-25       Impact factor: 1.730

6.  Group B Streptococcal Colonization Among Pregnant Women in Delhi, India.

Authors:  Manu Chaudhary; Marcia A Rench; Carol J Baker; Pushpa Singh; Charoo Hans; Morven S Edwards
Journal:  Pediatr Infect Dis J       Date:  2017-07       Impact factor: 2.129

7.  Group B Streptococcus detection in pregnant women via culture and PCR methods.

Authors:  Cláudia Wollheim; Rosa Dea Sperhacke; Sabrina Kahler Ribeiro Fontana; Andréa Cristina Vanni; Sérgio Kakuta Kato; Patricia Regina de Araújo; Afonso Luis Barth; José Mauro Madi
Journal:  Rev Soc Bras Med Trop       Date:  2017 Mar-Apr       Impact factor: 1.581

Review 8.  Intrapartum antibiotics for known maternal Group B streptococcal colonization.

Authors:  Arne Ohlsson; Vibhuti S Shah
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

9.  Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.

Authors: 
Journal:  Obstet Gynecol       Date:  2020-02       Impact factor: 7.661

10.  Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1996-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.